Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$PXMD - PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission

Indaptus Therapeutics: A Beacon of Hope in Cancer Treatment Unveiled at AACR Meeting.
In a groundbreaking presentation at the American Association for Cancer Research (AACR) Annual Meeting, Indaptus Therapeutics Inc. (NASDAQ: INDP) has shared promising data that could potentially revolutionize the way we approach cancer treatment. Their research focuses on the Decoy bacteria technology, an innovative method designed to prime the immune system both directly and indirectly, thereby enhancing its ability to effectively combat cancer. $Indaptus Therapeutics(INDP.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
1550 Views
Comment
Sign in to post a comment
    122Followers
    0Following
    278Visitors
    Follow